Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Prognostic significance of tumor doubling time in mass-forming type cholangiocarcinoma.

De Rose AM, Cucchetti A, Clemente G, Ardito F, Giovannini I, Ercolani G, Giuliante F, Pinna AD, Nuzzo G.

J Gastrointest Surg. 2013 Apr;17(4):739-47. doi: 10.1007/s11605-012-2129-6. Epub 2013 Jan 5.

PMID:
23292461
2.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
3.

Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.

Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, Adachi W, Amano J.

Hepatogastroenterology. 2002 Mar-Apr;49(44):311-6.

PMID:
11995440
4.

Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit.

Saxena A, Chua TC, Sarkar A, Chu F, Morris DL.

J Gastrointest Surg. 2010 Jul;14(7):1128-38. doi: 10.1007/s11605-010-1203-1. Epub 2010 May 14.

PMID:
20467830
5.

Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.

Li SQ, Liang LJ, Hua YP, Peng BG, He Q, Lu MD, Chen D.

Chin Med J (Engl). 2009 Oct 5;122(19):2286-91.

PMID:
20079127
6.

Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Yoon YI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Lee JW, Hong SM, Yu ES, Lee SG.

J Gastrointest Surg. 2016 Feb;20(2):411-20. doi: 10.1007/s11605-015-3045-3. Epub 2015 Dec 1.

PMID:
26628072
7.

A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.

Saito H, Noji T, Okamura K, Tsuchikawa T, Shichinohe T, Hirano S.

Surgery. 2016 Mar;159(3):842-51. doi: 10.1016/j.surg.2015.10.027. Epub 2015 Dec 10.

PMID:
26683498
8.

Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma.

Thelen A, Scholz A, Weichert W, Wiedenmann B, Neuhaus P, Gessner R, Benckert C, Jonas S.

Am J Gastroenterol. 2010 May;105(5):1123-32. doi: 10.1038/ajg.2009.674. Epub 2009 Dec 8.

PMID:
19997097
9.

Intrahepatic cholangiocarcinoma in Korea.

Kim HJ, Yun SS, Jung KH, Kwun WH, Choi JH.

J Hepatobiliary Pancreat Surg. 1999;6(2):142-8.

PMID:
10398901
10.

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR.

Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.

PMID:
18580211
11.

Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.

Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.

Ann Surg Oncol. 2010 Jul;17(7):1816-22. doi: 10.1245/s10434-010-0929-z. Epub 2010 Feb 5.

PMID:
20135355
12.

Serosal invasion in TNM staging of mass-forming intrahepatic cholangiocarcinoma.

Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Kubo S.

J Hepatobiliary Pancreat Surg. 2005;12(6):479-83.

PMID:
16365823
13.

Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment.

Li YY, Li H, Lv P, Liu G, Li XR, Tian BN, Chen DJ.

J Gastrointest Surg. 2011 Apr;15(4):608-13. doi: 10.1007/s11605-011-1419-8. Epub 2011 Jan 19.

PMID:
21246412
14.

Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.

Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM.

Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.

PMID:
18650638
15.

Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.

Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H.

Hepatogastroenterology. 2002 Mar-Apr;49(44):326-9.

PMID:
11995443
16.

[Analysis of prognostic factors after curative resection for combined hepatocellular and cholangiocarcinoma].

Kim W, Lee JH, Kim YJ, Yoon JH, Suh KS, Lee KU, Jang JJ, Lee HS.

Korean J Gastroenterol. 2007 Mar;49(3):158-65. Korean.

17.

Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors.

Klempnauer J, Ridder GJ, von Wasielewski R, Werner M, Weimann A, Pichlmayr R.

J Clin Oncol. 1997 Mar;15(3):947-54.

PMID:
9060532
18.

Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Sueda T.

J Surg Oncol. 2007 Mar 1;95(3):207-12.

PMID:
17278119
19.

Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.

Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, Cho CK.

Surg Today. 2014 Oct;44(10):1879-86. doi: 10.1007/s00595-014-0846-z. Epub 2014 Feb 18.

PMID:
24535697
20.

Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y.

Ann Surg. 2003 Nov;238(5):720-7.

Supplemental Content

Support Center